Literature DB >> 2394842

Antioxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract.

A M Cantin1, G A Fells, R C Hubbard, R G Crystal.   

Abstract

We hypothesized that the alveolar structures may contain extracellular macromolecules with antioxidant properties to defend against oxidants. To evaluate this 51Cr-labeled human lung fibroblasts (HFL-1) and cat lung epithelial cells (AKD) were exposed to a H2O2-generating system and alveolar epithelial lining fluid (ELF) from healthy nonsmokers was tested for its ability to protect the lung cells from H2O2-mediated injury. The ELF provided marked antioxidant protection, with most from a H2O-soluble fraction in the 100-300-kD range. Plasma proteins with anti-H2O2 properties were in insufficient concentrations to provide the antioxidant protection observed. However, catalase, a normal intracellular antioxidant, was present in sufficient concentration to account for most of the observed anti-H2O2 properties of ELF. Depletion of ELF with an anticatalase antibody abolished the anti-H2O2 macromolecular defenses of ELF. Since catalase is not normally released by cells, a likely explanation for its presence in high concentrations in normal ELF is that it is released by lung inflammatory and parenchymal cells onto the epithelial surface of the lower respiratory tract during their normal turnover and collects there due to the slow turnover of ELF. It is likely that catalase in the ELF of normal individuals plays a role in protecting lung parenchymal cells against oxidants present in the extracellular milieu.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394842      PMCID: PMC296816          DOI: 10.1172/JCI114798

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  The fate of enzymes in body fluids-an experimental study. I. Disappearance rates of glutamic-pyruvic transaminase under various conditions.

Authors:  G A FLEISHER; K G WAKIM
Journal:  J Lab Clin Med       Date:  1963-01

Review 2.  Superoxide dismutases.

Authors:  I Fridovich
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

3.  Effect of experimental saline lavage on pulmonary mechanics and morphology.

Authors:  G L Huber; L H Edmunds; T N Finley
Journal:  Am Rev Respir Dis       Date:  1971-09

4.  Fine structural identification of peroxisomes in mouse and rat bronchiolar and alveolar epithelium.

Authors:  P Petrik
Journal:  J Histochem Cytochem       Date:  1971-06       Impact factor: 2.479

5.  An improved procedure using ferricyanide for detecting catalase isozymes.

Authors:  W Woodbury; A K Spencer; M A Stahman
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

6.  Studies on microperoxisomes. II. A cytochemical method for light and electron microscopy.

Authors:  A B Novikoff; P M Novikoff; C Davis; N Quintana
Journal:  J Histochem Cytochem       Date:  1972-12       Impact factor: 2.479

7.  Human erythrocyte catalase: an improved method of isolation and a reevaluation of reported properties.

Authors:  J Bonaventura; W A Schroeder; S Fang
Journal:  Arch Biochem Biophys       Date:  1972-06       Impact factor: 4.013

8.  Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase.

Authors:  D E Paglia; W N Valentine
Journal:  J Lab Clin Med       Date:  1967-07

9.  Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells.

Authors:  R A Clark; S J Klebanoff; A B Einstein; A Fefer
Journal:  Blood       Date:  1975-02       Impact factor: 22.113

10.  Isolation and properties of phagocytic vesicles. II. Alveolar macrophages.

Authors:  T P Stossel; R J Mason; T D Pollard; M Vaughan
Journal:  J Clin Invest       Date:  1972-03       Impact factor: 14.808

View more
  26 in total

Review 1.  Pathogenesis of chronic obstructive pulmonary disease.

Authors:  William MacNee
Journal:  Proc Am Thorac Soc       Date:  2005

Review 2.  The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung disease.

Authors:  Carlo Dani; Chiara Poggi
Journal:  Antioxid Redox Signal       Date:  2014-02-19       Impact factor: 8.401

3.  Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin.

Authors:  B E Britigan; G T Rasmussen; C D Cox
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

4.  Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung.

Authors:  Neal S Gould; Elysia Min; Steven Gauthier; Hong Wei Chu; Richard Martin; Brian J Day
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 5.  Oxidative stress in COPD and its measurement through exhaled breath condensate.

Authors:  Wei Lee; Paul S Thomas
Journal:  Clin Transl Sci       Date:  2009-04       Impact factor: 4.689

Review 6.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

7.  Decreased peroxynitrite inhibitory activity in induced sputum in patients with bronchial asthma.

Authors:  H Kanazawa; S Shiraishi; K Hirata; J Yoshikawa
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

8.  Thiol-Redox Regulation in Lung Development and Vascular Remodeling.

Authors:  Gaston Ofman; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2019-03-04       Impact factor: 8.401

9.  Purification and characterization of catalase from goat (Capra capra) lung.

Authors:  U Chatterjee; G G Sanwal
Journal:  Mol Cell Biochem       Date:  1993-09-22       Impact factor: 3.396

10.  Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties.

Authors:  N Gilliard; G P Heldt; J Loredo; H Gasser; H Redl; T A Merritt; R G Spragg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.